166 related articles for article (PubMed ID: 9814695)
1. Lessons from experimental APS models.
Shoenfeld Y; Ziporen L
Lupus; 1998; 7 Suppl 2():S158-61. PubMed ID: 9814695
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome.
Shovman O; Gilburd B; Barzilai O; Langevitz P; Shoenfeld Y
Clin Rev Allergy Immunol; 2007 Apr; 32(2):145-52. PubMed ID: 17916984
[TBL] [Abstract][Full Text] [Related]
4. Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome.
Chapman J; Shoenfeld Y
Ann N Y Acad Sci; 2002 Jun; 966():415-24. PubMed ID: 12114299
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease.
Palomo I; Segovia F; Ortega C; Pierangeli S
Clin Exp Rheumatol; 2009; 27(4):668-77. PubMed ID: 19772805
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests.
Harris EN; Pierangeli SS; Gharavi AE
Lupus; 1998; 7 Suppl 2():S144-8. PubMed ID: 9814693
[TBL] [Abstract][Full Text] [Related]
9. Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model.
Haj-Yahia S; Sherer Y; Blank M; Kaetsu H; Smolinsky A; Shoenfeld Y
Lupus; 2003; 12(5):364-9. PubMed ID: 12765299
[TBL] [Abstract][Full Text] [Related]
10. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model.
Ziporen L; Polak-Charcon S; Korczyn DA; Goldberg I; Afek A; Kopolovic J; Chapman J; Shoenfeld Y
Clin Dev Immunol; 2004 Mar; 11(1):67-75. PubMed ID: 15154615
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
Greaves M
Haemostasis; 2000; 30 Suppl 2():16-25. PubMed ID: 11251337
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenic mechanisms of the anti-phospholipid antibodies].
Núñez-Álvarez CA; Cabiedes J
Reumatol Clin; 2011; 7(1):72-6. PubMed ID: 21794784
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.
Kolyada A; Porter A; Beglova N
Blood; 2014 Feb; 123(7):1090-7. PubMed ID: 24277078
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies: lessons from the bench.
Koike T; Bohgaki M; Amengual O; Atsumi T
J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
[TBL] [Abstract][Full Text] [Related]
16. Anti beta2-glycoprotein I antibodies: clinical significance.
Tincani A; Spatola L; Cinquini M; Cattaneo R; Meroni P; Balestrieri G
Lupus; 1998; 7 Suppl 2():S107-9. PubMed ID: 9814685
[TBL] [Abstract][Full Text] [Related]
17. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.
Ziporen L; Shoenfeld Y; Levy Y; Korczyn AD
J Clin Invest; 1997 Aug; 100(3):613-9. PubMed ID: 9239409
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Asherson RA; Cervera R; Merrill JT; Erkan D
Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
[TBL] [Abstract][Full Text] [Related]
19. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
Pierangeli SS; Harris EN
Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
[TBL] [Abstract][Full Text] [Related]
20. Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?
Meroni PL; Borghi MO; Grossi C; Chighizola CB; Durigutto P; Tedesco F
Nat Rev Rheumatol; 2018 Jul; 14(7):433-440. PubMed ID: 29891914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
